The secreted LOXL2 regulates integrin levels to promote tumor progression in renal clear cell carcinoma (ccRCC) by regulating lysyl oxidase LOXL2 status and its correlation with tumor staging (82). The gene discussed is LOXL2; the disease is nonpapillary renal cell carcinoma.